SCHEDULE: Rosalind Group Amends Myomo Stake Disclosure

Rosalind Advisors and affiliated entities have filed an amended Schedule 13G/A, disclosing their beneficial ownership in Myomo, Inc. at 9.51% of common stock.

Summary

• Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon collectively reported beneficial ownership in Myomo, Inc.
• As of June 30, 2025, the reporting persons beneficially owned 3,595,788 shares of Myomo, Inc. common stock.
• This represents approximately 9.51% of Myomo's common stock outstanding, based on 37,801,070 shares outstanding as of August 11, 2025.
• The filing also noted an aggregate of 7,359,046 shares, which includes 3,763,258 shares issuable upon exercise of pre-funded warrants.
• However, due to blocker provisions, the reporting persons were unable to exercise these warrants as of the event date, limiting their actual beneficial ownership to the common stock held directly.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While the filing is a factual disclosure, the continued significant stake by an investment group can be seen as a vote of confidence, despite the limitations imposed by blocker provisions on warrant exercise.

Positives

• A significant investment group, Rosalind Advisors and its affiliates, maintains a substantial stake in Myomo, Inc., indicating continued interest.

Negatives

• The inability to exercise pre-funded warrants due to blocker provisions limits the immediate increase in the reporting persons' ownership and potential influence.

Risks

• The existence of 'blocker provisions' in pre-funded warrants prevents the holder from exercising them if it would result in beneficial ownership exceeding 9.99% of the Common Stock, thereby limiting the investor's ability to increase their stake or influence beyond this threshold.

Future Outlook

This filing does not provide forward-looking statements or guidance regarding Myomo, Inc.'s future performance or strategic direction.

Industry Context

This filing is a routine disclosure of beneficial ownership by an investment group and does not provide specific insights into broader industry trends or competitive landscape for Myomo, Inc.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by an investment group provides transparency regarding major holders and their potential influence, though the blocker provisions limit immediate changes in control.

Key Dates

Keywords

Myomo Inc., Rosalind Advisors, Rosalind Master Fund, Beneficial Ownership, Schedule 13G/A, Common Stock, Pre-funded Warrants, Blocker Provision, Investment Fund, SEC Filing